Connect with us

Business

Vitality Biopharma Inc (OTCMKTS:VBIO) Launches Cannabinoid Pharmaceutical VITA-100

Published

on

Vitality Biopharma Inc

Vitality Biopharma Inc (OTCMKTS:VBIO) launched its lead cannabinoid medicine formulation VITA-100 as a prodrug of THC. The company has advanced a new class of cannabinoid prodrugs termed as cannabosides, which allow intended delivery of THC to the large intestine.

The buzz

THC has been earlier reviewed and permitted by the U.S. FDA under the name dronabinol. It has been established as effective and safe for application with appetite stimulation as well as for treatment of vomiting and nausea. Vitality Biopharma’s cannabosides could allow oral administration of large concentrations of cannabinoids so as to offer therapeutic benefits while eliminating or lowering psychoactivity by confining entry of THC into the brain or bloodstream.

Vitality Biopharma is focusing preliminary clinical development initiatives on VITA-100 and intends to conclude a first-in-man clinical trial in 1H2018. The treatment indications the firm intends to evaluate in Phase II studies comprise inflammatory bowel disease, narcotic bowel syndrome and irritable bowel syndrome, a grave type of opiate-induced abdominal pain.

Independent clinical study data indicate that THC can help result remission in Crohn’s disease and that 75% or more of IBD patients showed improvement in abdominal cramping and visceral pain with cannabinoid treatment. Over 1.4 million people in America have been reported to be suffering with IBD, which includes ulcerative colitis and Crohn’s disease. Most people with IBD are diagnosed before age of 30 years and need life-long treatment.

Robert Brooke, the Co-Founder and CEO of Vitality Biopharma, expressed that as independent clinical trials are showcasing the therapeutic effects of THC, they are well positioned with their VITA-100 gut-restricted prodrug offering. Several parents, pediatric gastroenterologists, and patients are eagerly seeking a treatment alternative that offers therapeutic benefits without the resulting psychoactivity. In advancing a THC prodrug, they will also benefit from a strong track record of history and safety of FDA drug approvals.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement